PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE GRADE 3 ENDOMETRIOID ADENOCANCER

被引：0
|
作者：
Gulec, U. Kucukgoz [1 ]
Bagir, E. [2 ]
Paydas, S. [3 ]
Guzel, A. B. [1 ]
Khatib, G. [1 ]
Seydaoglu, G. [4 ]
Vardar, M. A. [1 ]
机构：
[1] Cukurova Univ, Sch Med Obstet & Gynecol, Adana, Turkey
[2] Cukurova Univ, Sch Med, Pathol, Adana, Turkey
[3] Cukurova Univ, Sch Med, Med Oncol, Adana, Turkey
[4] Cukurova Univ, Sch Med, Biostat, Adana, Turkey
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-1350
引用
收藏
页码：1126 / 1126
页数：1
相关论文
共 50 条
  • [41] Programmed Death-Ligand 1 (PD-L1) Expression in Upper Tract Urothelial Carcinoma
    Skala, Stephanie
    Liu, Tzu-Ying
    MUdager, Aaron
    Weizei, Alon Z.
    Montgomery, Jeffrey S.
    Palapattu, Ganesh S.
    Siddiqui, Javed
    Cao, Xuhong
    Fields, Kristina
    Abugharib, Ahmed E.
    Soliman, Moaaz
    Hafez, Khaled S.
    Miller, David
    Lee, Cheryl T.
    Alva, Ajjai
    Chinnaiyan, Arul M.
    Morgan, Todd M.
    Sprott, Daniel E.
    Jiang, Hui
    Mehra, Rohit
    LABORATORY INVESTIGATION, 2017, 97 : 260A - 260A
  • [42] Programmed death-ligand 1 (PD-L1) and programmed cell death protein 1 (PD-1) expression in bladder cancer (BC): Differences in recurrent, progressive, and metastatic disease.
    Hegele, Axel
    Wahl, Franziska
    Rexin, Peter
    Nimphius, W.
    Hofmann, Rainer
    Haenze, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor
    Suteau, Valentine
    Collin, Alexandre
    Menei, Philippe
    Rodien, Patrice
    Rousselet, Marie-Christine
    Briet, Claire
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (10) : 2053 - 2061
  • [44] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non -Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    MODERN PATHOLOGY, 2017, 30 : 475A - 475A
  • [45] Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer
    Maureen L. Drakes
    Swati Mehrotra
    Monica Aldulescu
    Ronald K. Potkul
    Yueying Liu
    Anne Grisoli
    Cara Joyce
    Timothy E. O’Brien
    M. Sharon Stack
    Patrick J. Stiff
    Journal of Ovarian Research, 11
  • [46] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Matsuda, Kotaro
    Miyoshi, Hiroaki
    Hiraoka, Koji
    Hamada, Tetsuya
    Yoshida, Shiro
    Ishibashi, Yukinao
    Haraguchi, Toshiaki
    Shiba, Naoto
    Ohshima, Koichi
    CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (04) : 487 - 494
  • [47] Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand-1 (PD-L1) in ovarian cancer
    Drakes, Maureen L.
    Mehrotra, Swati
    Aldulescu, Monica
    Potkul, Ronald K.
    Liu, Yueying
    Grisoli, Anne
    Joyce, Cara
    O'Brien, Timothy E.
    Stack, M. Sharon
    Stiff, Patrick J.
    JOURNAL OF OVARIAN RESEARCH, 2018, 11
  • [48] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Kotaro Matsuda
    Hiroaki Miyoshi
    Koji Hiraoka
    Tetsuya Hamada
    Shiro Yoshida
    Yukinao Ishibashi
    Toshiaki Haraguchi
    Naoto Shiba
    Koichi Ohshima
    Clinical and Experimental Medicine, 2018, 18 : 487 - 494
  • [49] Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas
    Opal L. Reddy
    Peter I. Shintaku
    Neda A. Moatamed
    Diagnostic Pathology, 12
  • [50] Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Expression Patterns in Ewing and Ewing-Like Sarcoma
    Tamura, A.
    Yoshida, M.
    Yamamoto, N.
    Nakamura, S.
    Fujiwara, T.
    Tahara, T.
    Saito, A.
    Kozaki, A.
    Kishimoto, K.
    Ishida, T.
    Hasegawa, D.
    Kosaka, Y.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S336 - S336
12345